Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer

Journal of Surgical Oncology

Volumn 109, Issue 3, 2014, Pages 213-217

  Namikawa, Tsutomu ^a   Inoue, Keiji ^a   Uemura, Sunao ^a   Shiga, Mai ^a   Maeda, Hiromichi ^a   Kitagawa, Hiroyuki ^a   Fukuhara, Hideo ^a   Kobayashi, Michiya ^a   Shuin, Taro ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

5 aminolevulinic acid; adenocarcinoma; gastric cancer; photodynamic diagnosis; protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLUORESCENCE; GASTRECTOMY; HUMAN; LAPAROSCOPIC SURGERY; LIVER METASTASIS; MALE; MIDDLE AGED; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH TUBE; TOTAL STOMACH RESECTION; TUMOR VOLUME; VERY ELDERLY;

5-AMINOLEVULINIC ACID; ADENOCARCINOMA; GASTRIC CANCER; PHOTODYNAMIC DIAGNOSIS; PROTOPORPHYRIN IX;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FEASIBILITY STUDIES; FEMALE; FLUORESCENCE; GASTRECTOMY; HUMANS; INTRAOPERATIVE PERIOD; LAPAROSCOPY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHOTOSENSITIZING AGENTS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 84893682939     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23487     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Kelty CJ, Brown NJ, Reed MW, et al.: The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002; 1: 158-168.
3. Inoue K, Karashima T, Kamada M, et al.: Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Pathobiology 2009; 76: 303-314.
4. Inoue K, Fukuhara H, Shimamoto T, et al.: Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. Cancer 2012; 118: 1062-1074.
5. Loh CS, Vernon D, MacRobert AJ, et al.: Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B 1993; 20: 47-54.
6. Krieg RC, Messmann H, Rauch J, et al.: Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem Photobiol 2002; 76: 518-525.
7. Hinnen P, de Rooij FW, van Velthuysen ML, et al.: Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: A study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 1998; 78: 679-682.
8. Utsuki S, Miyoshi N, Oka H, et al.: Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: Pathological study. Brain Tumor Pathol 2007; 24: 53-55.
9. Fukuhara H, Inoue K, Satake H, et al.: Photodynamic diagnosis of positive margin during radical prostatectomy: Preliminary experience with 5-aminolevulinic acid. Int J Urol 2011; 18: 585-591.
10. Murayama Y, Ichikawa D, Koizumi N, et al.: Staging fluorescence laparoscopy for gastric cancer by using 5-aminolevulinic acid. Anticancer Res 2012; 32: 5421-5427.
11. Mayinger B, Reh H, Hochberger J, et al.: Endoscopic photodynamic diagnosis: Oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions. Gastrointest Endosc 1999; 50: 242-246.
12. Kishi K, Fujiwara Y, Yano M, et al.: Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer. J Surg Oncol 2012; 106: 294-298.
13. Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours, 7th edition. New York: Wiley-Blackwell; 2009.
14. Lauren P:, The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
15. Hagiya Y, Endo Y, Yonemura Y, et al.: Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro. Photodiagnosis Photodyn Ther 2012; 9: 204-214.
16. Kobuchi H, Moriya K, Ogino T, et al.: Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation. PLoS ONE 2012; 7: e50082.
17. Inoue K, Fukuhara H, Kurabayashi A, et al.: Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma. Cancer Sci 2013; 104: 765-772.
18. Mayinger B, Neidhardt S, Reh H, et al.: Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. Gastrointest Endosc 2001; 54: 572-578.
19. Loh CS, MacRobert AJ, Bedwell J, et al.: Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993; 68: 41-51.
20. Dalton JT, Yates CR, Yin D, et al.: Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer. J Pharmacol Exp Ther 2002; 301: 507-512.
21. Lam S, Palcic B, McLean D, et al.: Detection of early lung cancer using low dose Photofrin II. Chest 1990; 97: 333-337.
22. von Holstein CS, Nilsson AM, Andersson-Engels S, et al.: Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence. Gut 1996; 39: 711-716.